133 related articles for article (PubMed ID: 38147900)
21. Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
McCurdy JD; Kuenzig ME; Smith G; Spruin S; Murthy SK; Carrier M; Nguyen GC; Benchimol EI
Inflamm Bowel Dis; 2020 Oct; 26(11):1761-1768. PubMed ID: 31995204
[TBL] [Abstract][Full Text] [Related]
22. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis.
Burmester GR; Cohen SB; Winthrop KL; Nash P; Irvine AD; Deodhar A; Mysler E; Tanaka Y; Liu J; Lacerda AP; Palac H; Shaw T; Mease PJ; Guttman-Yassky E
RMD Open; 2023 Feb; 9(1):. PubMed ID: 36754548
[TBL] [Abstract][Full Text] [Related]
23. Risk of venous thromboembolism with inflammatory bowel disease.
Saleh T; Matta F; Yaekoub AY; Danescu S; Stein PD
Clin Appl Thromb Hemost; 2011 Jun; 17(3):254-8. PubMed ID: 20211927
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases.
Schneeweiss MC; Kim SC; Wyss R; Jin Y; Chin K; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S
JAMA Dermatol; 2021 Jul; 157(7):805-816. PubMed ID: 34037662
[TBL] [Abstract][Full Text] [Related]
25. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis.
Zhang XY; Dong HC; Wang WF; Zhang Y
World J Gastroenterol; 2022 Apr; 28(16):1705-1717. PubMed ID: 35581968
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002.
Cohen R; Robinson D; Paramore C; Fraeman K; Renahan K; Bala M
Inflamm Bowel Dis; 2008 Jun; 14(6):738-43. PubMed ID: 18300281
[TBL] [Abstract][Full Text] [Related]
27. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
28. Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort.
Vegh Z; Golovics PA; Lovasz BD; Kurti Z; Gecse KB; Szita I; Balogh M; Pandur T; Lakatos L; Lakatos PL
Scand J Gastroenterol; 2015 Mar; 50(3):306-11. PubMed ID: 25471148
[TBL] [Abstract][Full Text] [Related]
29. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women.
Li WQ; Han JL; Chan AT; Qureshi AA
Ann Rheum Dis; 2013 Jul; 72(7):1200-5. PubMed ID: 22941766
[TBL] [Abstract][Full Text] [Related]
30. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes.
Schmitt J; Schwarz K; Baurecht H; Hotze M; Fölster-Holst R; Rodríguez E; Lee YAE; Franke A; Degenhardt F; Lieb W; Gieger C; Kabesch M; Nöthen MM; Irvine AD; McLean WHI; Deckert S; Stephan V; Schwarz P; Aringer M; Novak N; Weidinger S
J Allergy Clin Immunol; 2016 Jan; 137(1):130-136. PubMed ID: 26253344
[TBL] [Abstract][Full Text] [Related]
31. Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors: A Systematic Review and Meta-analysis.
Chen TL; Lee LL; Huang HK; Chen LY; Loh CH; Chi CC
JAMA Dermatol; 2022 Nov; 158(11):1254-1261. PubMed ID: 36001310
[TBL] [Abstract][Full Text] [Related]
32. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
[TBL] [Abstract][Full Text] [Related]
33. Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims Database.
Meyers KJ; Silverberg JI; Rueda MJ; Goodloe R; Pierce EJ; Deberdt W; Brinker DR
Dermatol Ther (Heidelb); 2021 Jun; 11(3):1041-1052. PubMed ID: 33929715
[TBL] [Abstract][Full Text] [Related]
34. Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare.
Allen KD; Kiefer MK; Butnariu M; Afzali A
Arch Gynecol Obstet; 2022 Dec; 306(6):1929-1937. PubMed ID: 35249153
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
Alatri A; Schoepfer A; Fournier N; Engelberger RP; Safroneeva E; Vavricka S; Biedermann L; Calanca L; Mazzolai L;
Scand J Gastroenterol; 2016 Oct; 51(10):1200-5. PubMed ID: 27211077
[TBL] [Abstract][Full Text] [Related]
36. The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis.
Damian AC; Colaco K; Rohekar S; Boyd T; Chandran V; Gladman DD; Cook R; Eder L
Semin Arthritis Rheum; 2021 Jun; 51(3):547-552. PubMed ID: 33895651
[TBL] [Abstract][Full Text] [Related]
37. Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge.
McCurdy JD; Ellen Kuenzig M; Spruin S; Fung OW; Mallik R; Williams L; Murthy SK; Carrier M; Nguyen G; Benchimol EI
Dig Dis Sci; 2022 Jun; 67(6):2471-2479. PubMed ID: 34114153
[TBL] [Abstract][Full Text] [Related]
38. Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study.
He M; Pawar A; Desai RJ; Glynn RJ; Lee H; Weinblatt ME; Solomon DH; Kim SC
Semin Arthritis Rheum; 2021 Dec; 51(6):1242-1250. PubMed ID: 34757241
[TBL] [Abstract][Full Text] [Related]
39. The Incidence and Risk Factors of Venous Thromboembolism in Patients with Inflammatory Bowel Disease: A Prospective Multicenter Cohort Study.
Ando K; Fujiya M; Nomura Y; Inaba Y; Sugiyama Y; Kobayashi Y; Iwama T; Ijiri M; Takahashi K; Ueno N; Kashima S; Moriichi K; Tanabe H; Mizukami Y; Akasaka K; Fujii S; Yamada S; Nakase H; Okumura T
Digestion; 2019; 100(4):229-237. PubMed ID: 30554225
[TBL] [Abstract][Full Text] [Related]
40. Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis.
Yates M; Mootoo A; Adas M; Bechman K; Rampes S; Patel V; Qureshi S; Cope AP; Norton S; Galloway JB
Arthritis Rheumatol; 2021 May; 73(5):779-788. PubMed ID: 33174384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
